Waters Corporation

Biotechnology / Pharmaceuticals
WAT
$ 320 2.1
Share price
$ 19 bn
Market Cap
$ 19 bn
Enterprise Value

Carbon footprint

1.1 Ton
GHG emissions per $ 1 mln investment
0.04x the weighted average for S&P 500
FY2020
How is this calculated?
-6.5%
YOY change in GHG emissions
Weaker than the -11% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-5.6%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Stronger than the -5.1% weighted average for S&P 500
FY2021
How is this calculated?

Waters Corporation aims to reduce Scope 1 + 2 by 35% by 2025 from a base year 2016


This target has not been verified as science based according to SBTi
Waters Corporation's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

Waters Corporation's GHG emissions (market-based) (Kt of CO2e)

Waters Corporation's carbon footprint

Waters Corporation reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 22 Kt (-1.5 /-6.5% y-o-y).

Waters Corporation reported Scope 3 emissions for the the twelve months ending31 December 2020 at 22

The company is committed to reducing Scope 1 + 2 by 35% by 2025 from a base year 2016, which translates into the estimated reduction of -1.2 Kt per annum over the period of FY2021 - FY2025. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...